Literature DB >> 15690122

Autocrine proliferation of neuroblastoma cells is partly mediated through neurokinin receptors: relevance to bone marrow metastasis.

Indroneil Mukerji1, Shakti H Ramkissoon, Kavitha K R Reddy, Pranela Rameshwar.   

Abstract

Despite intensive therapy, approximately 60-80% of children who are diagnosed with metastatic neuroblastoma (NB) succumb to the disease. NB preferentially metastasizes to the bone marrow (BM). In the present study we used SY5Y and CHP212 (NB cell lines) to study the roles of the preprotachykinin-I (PPT-I) gene and the natural receptors for PPT-I peptides, neurokinin-1 (NK-1) and NK-2, in the biology of NB. PPT-I, NK-1 and NK-2 were constitutively expressed in the NB cells. Functional studies, with specific NK receptor antagonists, showed that PPT-I peptides mediate autocrine proliferation of the NB cells through both NK-1 and NK-2 receptors. Full-length and truncated NK-1 receptors were detected in NB cells. Since there is one copy of the NK-1 gene, we used NK-1-specific siRNA to suppress the expression of NK-1. The NK-1-deficient NB cells showed phenotypes consistent with cell differentiation. Suppression of NK-1 did not appear to cause cell death, as demonstrated by trypan blue exclusion and by undetectable active caspase. NK-1 suppression reduced the proliferation of the NB cells beginning by 10-fold at day 1 and reached a 10(5)-fold reduction by day 10. The NK-1 deficient cells did not proliferate when they were placed as cocultures with BM stroma, which suggests that NK-1 signaling is important for the survival of NB cells in the BM. The results show potential roles for NK receptors in the proliferation of NB.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15690122     DOI: 10.1007/s11060-004-9182-2

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  26 in total

1.  Migration and differentiation of neural precursor cells can be directed by microglia.

Authors:  Johan Aarum; Kristian Sandberg; Samantha L Budd Haeberlein; Mats A A Persson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-10       Impact factor: 11.205

2.  Human bone marrow angiogenesis: in vitro modulation by substance P and neurokinin A.

Authors:  Laurent Pelletier; Regis Angonin; Jacques Regnard; Dominique Fellmann; Pierre Charbord
Journal:  Br J Haematol       Date:  2002-12       Impact factor: 6.998

3.  Cloning of human preprotachykinin-I promoter and the role of cyclic adenosine 5'-monophosphate response elements in its expression by IL-1 and stem cell factor.

Authors:  J Qian; G Yehia; C Molina; A Fernandes; R Donnelly; D Anjaria; P Gascon; P Rameshwar
Journal:  J Immunol       Date:  2001-02-15       Impact factor: 5.422

4.  Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival.

Authors:  S G DuBois; Y Kalika; J N Lukens; G M Brodeur; R C Seeger; J B Atkinson; G M Haase; C T Black; C Perez; H Shimada; R Gerbing; D O Stram; K K Matthay
Journal:  J Pediatr Hematol Oncol       Date:  1999 May-Jun       Impact factor: 1.289

5.  P21Waf1/Cip1 dysfunction in neuroblastoma: a novel mechanism of attenuating G0-G1 cell cycle arrest.

Authors:  Pamela P McKenzie; Mary K Danks; Richard W Kriwacki; Linda C Harris
Journal:  Cancer Res       Date:  2003-07-01       Impact factor: 12.701

6.  Differences in the expression of neurokinin receptor in neural and bone marrow mesenchymal cells: implications for neuronal expansion from bone marrow cells.

Authors:  P S Bandari; J Qian; G Yehia; H P Seegopaul; J S Harrison; P Gascon; H Fernandes; P Rameshwar
Journal:  Neuropeptides       Date:  2002-02       Impact factor: 3.286

Review 7.  Advances in the diagnosis and treatment of neuroblastoma.

Authors:  Joanna L Weinstein; Howard M Katzenstein; Susan L Cohn
Journal:  Oncologist       Date:  2003

8.  Bone marrow stroma influences transforming growth factor-beta production in breast cancer cells to regulate c-myc activation of the preprotachykinin-I gene in breast cancer cells.

Authors:  Hyun S Oh; Anabella Moharita; Joseph G Potian; Ian P Whitehead; Jason C Livingston; Tammy A Castro; Prem S Patel; Pranela Rameshwar
Journal:  Cancer Res       Date:  2004-09-01       Impact factor: 12.701

9.  Crosstalk between neurokinin receptors is relevant to hematopoietic regulation: cloning and characterization of neurokinin-2 promoter.

Authors:  Persis S Bandari; Jing Qian; Hyun S Oh; Julius A Potian; Ghassan Yehia; Jonathan S Harrison; Pranela Rameshwar
Journal:  J Neuroimmunol       Date:  2003-05       Impact factor: 3.478

10.  Neurokinin-1 receptor expression and its potential effects on tumor growth in human pancreatic cancer.

Authors:  Helmut Friess; Zhaowen Zhu; Veronique Liard; Xin Shi; Shailesh V Shrikhande; Li Wang; Klaus Lieb; Murray Korc; Carla Palma; Arthur Zimmermann; Jean Claude Reubi; Markus W Büchler
Journal:  Lab Invest       Date:  2003-05       Impact factor: 5.662

View more
  4 in total

Review 1.  Tachykinins and their receptors: contributions to physiological control and the mechanisms of disease.

Authors:  Martin S Steinhoff; Bengt von Mentzer; Pierangelo Geppetti; Charalabos Pothoulakis; Nigel W Bunnett
Journal:  Physiol Rev       Date:  2014-01       Impact factor: 37.312

Review 2.  The significance of substance P in physiological and malignant haematopoiesis.

Authors:  Michal Nowicki; Danuta Ostalska-Nowicka; Beata Kondraciuk; Bogdan Miskowiak
Journal:  J Clin Pathol       Date:  2006-12-15       Impact factor: 3.411

Review 3.  Involvement of substance P and the NK-1 receptor in pancreatic cancer.

Authors:  Miguel Muñoz; Rafael Coveñas
Journal:  World J Gastroenterol       Date:  2014-03-07       Impact factor: 5.742

Review 4.  The substance P/NK-1 receptor system: NK-1 receptor antagonists as anti-cancer drugs.

Authors:  Miguel Munoz; Rafael Covenas; Francisco Esteban; Maximino Redondo
Journal:  J Biosci       Date:  2015-06       Impact factor: 1.826

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.